FDA Inspection 1175099 — Cell Therapy And Graft Engineering, RUSH University Medical Center

Cell Therapy And Graft Engineering, RUSH University Medical Center — FEI 3015932579

The FDA completed an inspection of Cell Therapy And Graft Engineering, RUSH University Medical Center on May 25, 2022 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.